255 related articles for article (PubMed ID: 25684370)
41. An EP4 Receptor Agonist Inhibits Cardiac Fibrosis Through Activation of PKA Signaling in Hypertrophied Heart.
Wang Q; Oka T; Yamagami K; Lee JK; Akazawa H; Naito AT; Yasui T; Ishizu T; Nakaoka Y; Sakata Y; Komuro I
Int Heart J; 2017 Feb; 58(1):107-114. PubMed ID: 27829645
[TBL] [Abstract][Full Text] [Related]
42. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.
Chen J; Shearer GC; Chen Q; Healy CL; Beyer AJ; Nareddy VB; Gerdes AM; Harris WS; O'Connell TD; Wang D
Circulation; 2011 Feb; 123(6):584-93. PubMed ID: 21282499
[TBL] [Abstract][Full Text] [Related]
43. Bacillus Calmette-Guérin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment.
Liu YY; Cai WF; Yang HZ; Cui B; Chen ZR; Liu HZ; Yan J; Jin W; Yan HM; Xin BM; Yuan B; Hua F; Hu ZW
J Immunol; 2008 Jun; 180(11):7349-57. PubMed ID: 18490734
[TBL] [Abstract][Full Text] [Related]
44. Receptor activator of nuclear factor-κB ligand is a novel inducer of myocardial inflammation.
Ock S; Ahn J; Lee SH; Park H; Son JW; Oh JG; Yang DK; Lee WS; Kim HS; Rho J; Oh GT; Abel ED; Park WJ; Min JK; Kim J
Cardiovasc Res; 2012 Apr; 94(1):105-14. PubMed ID: 22298642
[TBL] [Abstract][Full Text] [Related]
45. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.
Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ
Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721
[TBL] [Abstract][Full Text] [Related]
46. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
47. Hesperetin protects against cardiac remodelling induced by pressure overload in mice.
Deng W; Jiang D; Fang Y; Zhou H; Cheng Z; Lin Y; Zhang R; Zhang J; Pu P; Liu Y; Bian Z; Tang Q
J Mol Histol; 2013 Oct; 44(5):575-85. PubMed ID: 23719775
[TBL] [Abstract][Full Text] [Related]
48. Induction of heart failure by minimally invasive aortic constriction in mice: reduced peroxisome proliferator-activated receptor γ coactivator levels and mitochondrial dysfunction.
Faerber G; Barreto-Perreia F; Schoepe M; Gilsbach R; Schrepper A; Schwarzer M; Mohr FW; Hein L; Doenst T
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):492-500, 500.e1. PubMed ID: 20447656
[TBL] [Abstract][Full Text] [Related]
49. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
[TBL] [Abstract][Full Text] [Related]
50. A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Liu W; Zi M; Tsui H; Chowdhury SK; Zeef L; Meng QJ; Travis M; Prehar S; Berry A; Hanley NA; Neyses L; Xiao RP; Oceandy D; Ke Y; Solaro RJ; Cartwright EJ; Lei M; Wang X
Circ Heart Fail; 2013 Jul; 6(4):833-44. PubMed ID: 23753531
[TBL] [Abstract][Full Text] [Related]
51. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity.
Ryu Y; Jin L; Kee HJ; Piao ZH; Cho JY; Kim GR; Choi SY; Lin MQ; Jeong MH
Sci Rep; 2016 Oct; 6():34790. PubMed ID: 27703224
[TBL] [Abstract][Full Text] [Related]
52. Regulation of the aldo-keto reductase gene akr1b7 by the nuclear oxysterol receptor LXRalpha (liver X receptor-alpha) in the mouse intestine: putative role of LXRs in lipid detoxification processes.
Volle DH; Repa JJ; Mazur A; Cummins CL; Val P; Henry-Berger J; Caira F; Veyssiere G; Mangelsdorf DJ; Lobaccaro JM
Mol Endocrinol; 2004 Apr; 18(4):888-98. PubMed ID: 14739254
[TBL] [Abstract][Full Text] [Related]
53. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
[TBL] [Abstract][Full Text] [Related]
54. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.
Huang H; Tang QZ; Wang AB; Chen M; Yan L; Liu C; Jiang H; Yang Q; Bian ZY; Bai X; Zhu LH; Wang L; Li H
Hypertension; 2010 Aug; 56(2):232-9. PubMed ID: 20585109
[TBL] [Abstract][Full Text] [Related]
56. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
57. LXRα improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes.
Cannon MV; Silljé HH; Sijbesma JW; Khan MA; Steffensen KR; van Gilst WH; de Boer RA
Diabetologia; 2016 Mar; 59(3):634-43. PubMed ID: 26684450
[TBL] [Abstract][Full Text] [Related]
58. Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload.
Shi C; Zijlstra SN; de Wit S; Meijers WC; Aboumsallem JP; Silljé HHW; de Boer RA
Am J Physiol Heart Circ Physiol; 2023 Jul; 325(1):H195-H201. PubMed ID: 37294894
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of IκB phosphorylation prevents load-induced cardiac dysfunction in mice.
Tanaka T; Ogawa M; Suzuki J; Sekinishi A; Itai A; Hirata Y; Nagai R; Isobe M
Am J Physiol Heart Circ Physiol; 2012 Dec; 303(12):H1435-45. PubMed ID: 23042949
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of SMAD2 phosphorylation preserves cardiac function during pressure overload.
Bjørnstad JL; Skrbic B; Marstein HS; Hasic A; Sjaastad I; Louch WE; Florholmen G; Christensen G; Tønnessen T
Cardiovasc Res; 2012 Jan; 93(1):100-10. PubMed ID: 22049534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
